Aurelius Data is the first global big data company using Deep Learning to analyze, predict, and find new cures, market trends, IP and patent gaps in the cannabis and psilocybin markets.
If you are interested in more information, please contact us at email@example.com.
Pharmacist, Cancer survivor, top S&P 50 career refugee, elected official, equestrian. Laser focused and relentless. Deep knowledge of the pharmaceutical industry and medical sciences. Skilled at navigating government and regulatory environments. I naively believe I can make everything, and everyone, better. Lover of English bulldogs, which directly contradicts my passion for good design and process improvement.
Experienced pharmaceutical professional, executive, operator, project manager, and marketer. I have a passion for improving patient health outcomes delivered with technological and product innovation, delivered with an exceptional quality. Extensive knowledge and experience in the pharmaceutical, healthcare, IT, retail and specialty pharmacy sectors. Knowledge of patient adherence solutions, pharmacy technology solutions, physician and patient education, clinical trials supply chain management, pharma logistics, business, marketing, and branding strategy.
James is one of the most highly capable, creative and mentally flexible polymaths in this space. His ability to execute scientific analysis is unparalleled. Fully mercenary when it comes to the company, he turns to mush when talking about his kids.
Developed, piloted, and placed into commercial operation a variety of scaled extraction systems for biopolymers, flavors, fragrances, and bioactive compounds for food, beverage, cosmetic, and pharmaceutical applications, including systems for the extraction and separation of CBD, CBN, CBC, CBG, and THC. Personally, developed over 90 natural and biomimetic pathways for biopolymers, specialty chemicals, and functional ingredients. Has lead teams in the development of over 1000 functional compounds or compound mixtures, including derivatives and isolates of both common and rare cannabinoid compounds.
Has personal relationships and has done cutting edge development and commercializaton projects for Anheusuer Busch, AB-Inbev, Ajinomoto, Amway, Boeing, Brain AG, Cargill, Conagra, Corixa (GSK), Department of Defense, Department of State, Dunkin Donuts, Estee Lauder, Firmenich, Green Biologics, Kraft, Kraft Heinz, Lush Cosmetics, Method, Merck, Mondelez, Symrise, and Welches.